“In Spain, we don’t face the long waiting lists that are common in other countries with open-identity laws,” Dr ...

Most Americans, including doctors, have no memory of the devastating diseases that routinely threatened children until the ...

Raine Talley, a West Chester native, overcame leukemia as a child, but the treatment left her with several long-term effects, ...

Targeting the source of indolent systemic mastocytosis may unlock a new way to live with its potentially debilitating, ...

Heranova, a leader in women's health innovation, is excited to announce the launch of HerResolve™, a groundbreaking ...

Roche's Vabysmo® (faricimab) prefilled syringe has received European Medicines Agency approval for treating three major ...

Advertisment SUI is a common condition affecting individuals, particularly women, and can significantly impact quality of ...

Glioblastoma, an aggressive brain cancer, syncs its internal clock to the host’s circadian rhythms, leveraging daily hormone ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Our future depends on every child from every corner of Idaho receiving a great education. But when the Idaho Legislature ...

HONG KONG, Dec. 13, 2024 /PRNewswire/ -- Heranova, a leader in women's health innovation, is excited to announce the launch of HerResolve™, a groundbreaking non-invasive test for endometriosis, at the ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will receive a US$10 million milestone payment by its partner Takeda (TSE:4502/NYSE:TAK). Takeda received a national ...